乐伐替尼与肝细胞癌相关的严重低血糖症

Lenvatinib in severe hypoglycemia associated with hepatocellular carcinoma.

作者信息

Gómez Torres Katherine Milagros, Molina Villalba Carmen, Estévez Escobar Matías

机构信息

UGC Aparato Digestivo, Hospital de Poniente, España.

出版信息

Rev Esp Enferm Dig. 2021 Nov;113(11):799. doi: 10.17235/reed.2021.8016/2021.

DOI:10.17235/reed.2021.8016/2021

PMID:33947193

Abstract

We present the case of a 24-year-old male with multicentric hepatocellular carcinoma (HCC) over HBV-related compensated liver cirrhosis, on treatment with sorafenib and tenofovir. He had multiple admissions in recent months for severe hypoglycemia episodes with neurological symptoms.

摘要

我们报告了一例24岁男性病例，患有多中心肝细胞癌（HCC），基础为乙肝相关代偿期肝硬化，正在接受索拉非尼和替诺福韦治疗。他在最近几个月因严重低血糖发作伴神经症状多次入院。